Literature DB >> 25251469

Attenuation of cocaine-induced locomotor activity in male and female mice by active immunization.

Therese A Kosten1, Xiaoyun Y Shen, Berma M Kinsey, Thomas R Kosten, Frank M Orson.   

Abstract

BACKGROUND AND OBJECTIVES: Immunotherapy for drug addiction is being investigated in several laboratories but most studies are conducted in animals of one sex. Yet, women show heightened immune responses and are more likely to develop autoimmune diseases than men. The purpose of this study was to compare the effects of an active anti-cocaine vaccine, succinyl-norcocaine conjugated to keyhole limpet hemocyanin, for its ability to elicit antibodies and alter cocaine-induced ambulatory activity in male versus female mice.
METHODS: Male and female BALB/c mice were vaccinated (n = 44) or served as non-vaccinated controls (n = 34). Three weeks after initial vaccination, a booster was given. Ambulatory activity induced by cocaine (20 mg/kg) was assessed at 7 weeks and plasma obtained at 8 weeks to assess antibody levels.
RESULTS: High antibody titers were produced in mice of both sexes. The vaccine reduced ambulatory activity cocaine-induced but this effect was greater in female compared to male mice. DISCUSSION AND
CONCLUSIONS: The efficacy of this anti-cocaine vaccine is demonstrated in mice of both sexes but its functional consequences are greater in females than males. SCIENTIFIC SIGNIFICANCE: Results point to the importance of testing animals of both sexes in studies of immunotherapies for addiction. © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25251469      PMCID: PMC4184912          DOI: 10.1111/j.1521-0391.2014.12152.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  36 in total

1.  Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans.

Authors:  L A Marsch; W K Bickel; G J Badger; J P Rathmell; M D Swedberg; B Jonzon; C Norsten-Höög
Journal:  J Pharmacol Exp Ther       Date:  2001-12       Impact factor: 4.030

2.  The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats.

Authors:  D C Roberts; S A Bennett; G J Vickers
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Gender differences in cocaine use and treatment response.

Authors:  T A Kosten; F H Gawin; T R Kosten; B J Rounsaville
Journal:  J Subst Abuse Treat       Date:  1993 Jan-Feb

4.  Rate of increase of plasma drug level influences subjective response in humans.

Authors:  H de Wit; B Bodker; J Ambre
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Suppression of psychoactive effects of cocaine by active immunization.

Authors:  M R Carrera; J A Ashley; L H Parsons; P Wirsching; G F Koob; K D Janda
Journal:  Nature       Date:  1995-12-14       Impact factor: 49.962

6.  Efficacy of a therapeutic cocaine vaccine in rodent models.

Authors:  B S Fox; K M Kantak; M A Edwards; K M Black; B K Bollinger; A J Botka; T L French; T L Thompson; V C Schad; J L Greenstein; M L Gefter; M A Exley; P A Swain; T J Briner
Journal:  Nat Med       Date:  1996-10       Impact factor: 53.440

7.  Glycoprotein-D-adjuvant vaccine to prevent genital herpes.

Authors:  Lawrence R Stanberry; Spotswood L Spruance; Anthony L Cunningham; David I Bernstein; Adrian Mindel; Stephen Sacks; Stephen Tyring; Fred Y Aoki; Moncef Slaoui; Martine Denis; Pierre Vandepapeliere; Gary Dubin
Journal:  N Engl J Med       Date:  2002-11-21       Impact factor: 91.245

8.  Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice.

Authors:  M Benuck; A Lajtha; M E Reith
Journal:  J Pharmacol Exp Ther       Date:  1987-10       Impact factor: 4.030

9.  Relationship between injection duration, transporter occupancy and reinforcing strength of cocaine.

Authors:  William L Woolverton; Zhixia Wang
Journal:  Eur J Pharmacol       Date:  2004-02-23       Impact factor: 4.432

10.  A second-generation vaccine protects against the psychoactive effects of cocaine.

Authors:  M R Carrera; J A Ashley; P Wirsching; G F Koob; K D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more
  4 in total

1.  Housing conditions and microbial environment do not affect the efficacy of vaccines for treatment of opioid use disorders in mice and rats.

Authors:  Bethany Crouse; Li Zhang; Christine Robinson; Yuguang Ban; Jennifer R Vigliaturo; Sabita Roy; Marco Pravetoni
Journal:  Hum Vaccin Immunother       Date:  2021-08-19       Impact factor: 4.526

2.  Active vaccination attenuates the psychostimulant effects of α-PVP and MDPV in rats.

Authors:  Jacques D Nguyen; Paul T Bremer; Alex Ducime; Kevin M Creehan; Brent R Kisby; Michael A Taffe; Kim D Janda
Journal:  Neuropharmacology       Date:  2016-12-09       Impact factor: 5.250

3.  Pharmacological mechanisms underlying the efficacy of antibodies generated by a vaccine to treat oxycodone use disorder.

Authors:  M D Raleigh; S J King; F Baruffaldi; A Saykao; F A Hamid; S Winston; M G LeSage; P R Pentel; M Pravetoni
Journal:  Neuropharmacology       Date:  2021-06-11       Impact factor: 5.273

4.  Single Low Dose of Cocaine-Structural Brain Injury Without Metabolic and Behavioral Changes.

Authors:  Camilla Nicolucci; Mariana Lapo Pais; A C Santos; Fabiana M Ribeiro; Pedro M C C Encarnação; Ana L M Silva; I F Castro; Pedro M M Correia; João F C A Veloso; Julie Reis; Marina Z Lopes; Maria F Botelho; Frederico C Pereira; Denise G Priolli
Journal:  Front Neurosci       Date:  2021-01-22       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.